《新股消息》內地線上保險中介商「手回科技」遞交上市申請
中國線上人身險中介服務提供商「手回科技」近日向聯交所提交上市申請,由中金公司及華泰國際擔任聯席保薦人。
手回科技通過小雨傘、(口卡)嚓保和牛保100三大平台,分別經營在線直接銷售解決方案、賦能代理人營銷科技解決方案及為業務合作夥伴提供營銷科技解決方案,截至去年9月底止三個平台累計註冊用戶數量超過1,800萬,累計投保人數量超過280萬,累計被保險人數超過420萬。
初步招股資料顯示,手回科技去年首九個月收入為13.36億元人民幣,按年增長1.4倍,期內錄虧損2.87億元人民幣,對比對上財年同期錄利潤近1.48億元人民幣。
是次集資所得預期將用於用於開發保險產品及改善服務;提升研發能力及改進技術基礎設施;兼併、收購及戰略投資;以及營運資金及一般公司用途。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.